Drawing for RNASKY

USPTO serial 79400159

RNASKY

Reviewed by CopyMark Law Group

Reg. 7629100Status 700Registered
Filing date
Status date
Registration date
Dec 31, 2024
Examiner
FOSTER, SHATONI A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RNASKY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHELLE LEVIN

MICHELLE LEVIN Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biological and biochemical products for industrial, scientific purposes, namely, peptides, fluorescent dyes and conjugates thereof for use in separation processes for biological materials; reagents for cell separation; reagents for DNA, RNA, and polynucleotide detection; reagents for amplification, sequencing and detection of genetic material; reagents for Polymerase Chain Reaction (PCR); in situ polynucleotide detection reagents; in situ hybridization (ISH) reagents; fluorescence in situ hybridization (FISH) reagents; polynucleotide hybridization reagents; spatial multi-omics reagents; spatial transcriptomics reagents; polynucleotide detection probes; labeling reagents; media for cell culture for research laboratories; substances and ingredients for the preparation of media; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological material; reagents with magnetic beads; tissue staining reagents; antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, namely, imaging instruments, reagents for processing of biological material, namely, tissue, bone marrow, cells, blood other than for medical or veterinary purposes; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, and in the biotechnology industry; enzymes, other than for medical or veterinary use; polynucleotides, polynucleotide, DNA, and RNA primers and probes, fluorescence primers and probes, fluorophores, chemical additives for dyeing, all for scientific purposes; all the above for industrial or scientific purposesACTIVE—
002Primers and surgical dyes for use in pharmaceutical or scientific industriesACTIVE—
005Nucleotides, polynucleotides, polynucleotides, namely, primers or probes for dna and rna, fluorescence primers and probes, complexes of molecules; all for medical purposesACTIVE—
009Apparatus for imaging for use in the study of spatial biology imaging; Scientific laboratory research instruments for polynucleotide sequencing; scientific laboratory research instruments for amplification and detection of genetic material; scientific laboratory research instruments for tissue visualization, in situ hybridization (ISH) instruments, fluorescence in situ hybridization (FISH) instruments; Scientific apparatus, namely, for spatial multi-omics and spatial transcriptomics for use in the science industry; apparatus for histology, namely, fluorescent imaging apparatuses and microscopes all for scientific purposes; histopathology slides and chambers; all the aforesaid being for laboratory useACTIVE—
010Medical imaging apparatus; instruments for spatial biology; instruments for polynucleotide sequencing; instruments for amplification and detection of genetic material; instruments for tissue visualization, in situ hybridization (ISH) instruments, fluorescence in situ hybridization (FISH) instruments; Polymerase Chain Reaction (PCR) instruments; apparatus for spatial multi-omics and spatial transcriptomics; apparatus for histology, all for medical and diagnostic purposes; histopathology slides and chambers; columns for analysis for medical purposes; all the aforementioned for medical purposes; apparatus and instruments for medical purposesACTIVE—
042Scientific and technological services, namely, research and design services; services for design of polynucleotide probes and genetic panels; all of the aforementioned services for and in connection with detection, localization and analysis of proteins and genetic material for biological and medical research, medical diagnostics and therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 1, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 17, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 17, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 18, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 18, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 19, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 2, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 2, 2025FIMPFINAL DISPOSITION PROCESSED—
Apr 1, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 31, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 31, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2024RFNTREFUSAL PROCESSED BY IB—
Aug 22, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 22, 2024RFRRREFUSAL PROCESSED BY MPU—
Aug 16, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 15, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2024DOCKASSIGNED TO EXAMINER—
Jul 25, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 25, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 18, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance